Tci Gene Inc.(TW:6879)
NT$35.500.00 (0.00%)
TW:6879
Tci Gene Inc. financials statements
NT$35.50
At close:0.00 (0.00%)
Tci Gene Inc. (6879) Income Statement
Tci Gene Inc. Income Statement
Last quarter (Q2 2026), Tci Gene Inc.'s total revenue was NT$119.49M, a decrease of 27.37% from the same quarter last year. In Q2, Tci Gene Inc.'s net income was NT$13.15M. See Tci Gene Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 273.61M | NT$ 347.54M | NT$ 333.86M | NT$ 424.02M | NT$ 432.22M | |
| NT$ 152.59M | NT$ 204.07M | NT$ 174.62M | NT$ 243.36M | NT$ 239.43M | |
| NT$ 131.65M | NT$ 148.30M | NT$ 168.69M | NT$ 152.26M | NT$ 125.86M | |
| Depreciation and Amortization | NT$ 11.98M | NT$ 13.80M | NT$ 15.93M | NT$ 29.65M | NT$ 37.84M |
| NT$ 32.91M | NT$ 81.85M | NT$ 25.89M | NT$ 121.16M | NT$ 155.43M | |
| NT$ 20.93M | NT$ 52.50M | NT$ 5.93M | NT$ 90.56M | NT$ 113.57M | |
| NT$ 18.04M | NT$ 15.06M | NT$ 2.85M | NT$ -432.00K | NT$ 3.19M | |
| NT$ 38.97M | NT$ 67.56M | NT$ 8.78M | NT$ 90.13M | NT$ 116.44M | |
| NT$ 40.57M | NT$ 56.31M | NT$ 11.67M | NT$ 72.14M | NT$ 92.45M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.53 | NT$ 2.12 | NT$ 0.44 | NT$ 2.95 | NT$ 4.84 |
| Diluted EPS | NT$ 1.53 | NT$ 2.12 | NT$ 0.44 | NT$ 2.93 | NT$ 4.67 |
| Weighted Average Shares Outstanding | 25.54M | 26.46M | 26.48M | 24.49M | 19.11M |
| Weighted Average Shares Outstanding (Diluted) | 25.54M | 26.51M | 26.48M | 24.59M | 19.79M |
Currency in TWD

